INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 216 filers reported holding INARI MED INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,629,290 | +16.0% | 1,446,931 | +3.1% | 0.16% | +22.0% |
| Q2 2023 | $81,586,355 | +1.1% | 1,403,274 | +7.3% | 0.13% | -7.3% |
| Q1 2023 | $80,726,288 | +6.7% | 1,307,520 | +9.8% | 0.14% | -2.8% |
| Q4 2022 | $75,664,094 | -5.4% | 1,190,436 | +8.1% | 0.14% | -9.6% |
| Q3 2022 | $80,014,000 | +5.1% | 1,101,520 | -1.6% | 0.16% | +9.1% |
| Q2 2022 | $76,099,000 | +16.7% | 1,119,275 | +55.6% | 0.14% | +47.4% |
| Q1 2022 | $65,220,000 | +16.6% | 719,551 | +17.4% | 0.10% | +40.6% |
| Q4 2021 | $55,954,000 | +33.7% | 613,062 | +18.8% | 0.07% | +11.3% |
| Q3 2021 | $41,850,000 | -4.7% | 516,030 | +9.6% | 0.06% | -6.1% |
| Q2 2021 | $43,907,000 | -3.4% | 470,693 | +10.8% | 0.07% | -15.4% |
| Q1 2021 | $45,448,000 | +24.8% | 424,750 | +1.8% | 0.08% | +20.0% |
| Q4 2020 | $36,418,000 | +43.7% | 417,197 | +13.6% | 0.06% | +25.0% |
| Q3 2020 | $25,347,000 | +46.7% | 367,233 | +3.0% | 0.05% | +30.0% |
| Q2 2020 | $17,278,000 | – | 356,696 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |